Literature DB >> 30269956

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density.

Naoko Mori1, Hiroyuki Abe2, Shunji Mugikura3, Chiaki Takasawa3, Satoko Sato4, Minoru Miyashita5, Yu Mori6, Federico D Pineda2, Gregory S Karczmar2, Hajime Tamura7, Shoki Takahashi3, Kei Takase3.   

Abstract

RATIONALE AND
OBJECTIVES: To evaluate whether parameters from empirical mathematical model (EMM) for ultrafast dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) correlate with histological microvessel density (MVD) in invasive breast cancer.
MATERIALS AND METHODS: Ninety-eight consecutive patients with invasive breast cancer underwent an institutional review board-approved ultrafast DCE-MRI including a pre- and 18 postcontrast whole breast ultrafast scans (3 seconds) followed by four standard scans (60 seconds) using a 3T system. Region of interest was placed within each lesion where the highest signal increase was observed on ultrafast DCE-MRI, and the increase rate of enhancement was calculated as follows: ΔS = (SIpost - SIpre)/SIpre. The kinetic curve obtained from ultrafast DCE-MRI was analyzed using a truncated EMM: ΔS(t) = A(1 - e-αt), where A is the upper limit of the signal intensity, α (min-1) is the rate of signal increase. The initial slope of the kinetic curve is given by Aα. Initial area under curve (AUC30) and time of initial enhancement was calculated. From the standard DCE-MRI, the initial enhancement rate (IER) and the signal enhancement ratio (SER) were calculated as follows: IER = (SIearly - SIpre)/SIpre, SER = (SIearly - SIpre)/(SIdelayed - SIpre). The parameters were compared to MVD obtained from surgical specimens.
RESULTS: A, α, Aα, AUC30, and time of initial enhancement significantly correlated with MVD (r = 0.29, 0.40, 0.51, 0.43, and -0.32 with p = 0.0027, p < 0.0001, p < 0.0001, p < 0.0001, and p = 0.0012, respectively), whereas IER and SER from standard DCE-MRI did not.
CONCLUSION: The parameters of the EMM, especially the initial slope or Aα, for ultrafast DCE-MRI correlated with MVD in invasive breast cancer.
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Dynamic contrast-enhanced MRI; Magnetic resonance imaging; Microvessels

Mesh:

Substances:

Year:  2018        PMID: 30269956      PMCID: PMC6535127          DOI: 10.1016/j.acra.2018.08.016

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  36 in total

Review 1.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

Review 2.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

3.  Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma.

Authors:  B Wang; Z Q Gao; X Yan
Journal:  Acta Radiol       Date:  2005-07       Impact factor: 1.990

4.  Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patterns.

Authors:  Esther H Adler; Jaya L Sunkara; Arthur S Patchefsky; Leopold G Koss; Maja H Oktay
Journal:  Hum Pathol       Date:  2011-09-16       Impact factor: 3.466

5.  Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma.

Authors:  M Toi; J Kashitani; T Tominaga
Journal:  Int J Cancer       Date:  1993-09-30       Impact factor: 7.396

6.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

7.  CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.

Authors:  C Charpin; B Devictor; D Bergeret; L Andrac; J Boulat; N Horschowski; M N Lavaut; L Piana
Journal:  Am J Clin Pathol       Date:  1995-04       Impact factor: 2.493

Review 8.  Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.

Authors:  Anwar R Padhani
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

9.  A novel approach to contrast-enhanced breast magnetic resonance imaging for screening: high-resolution ultrafast dynamic imaging.

Authors:  Ritse M Mann; Roel D Mus; Jan van Zelst; Christian Geppert; Nico Karssemeijer; Bram Platel
Journal:  Invest Radiol       Date:  2014-09       Impact factor: 6.016

10.  Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.

Authors:  Y Nieto; J Woods; F Nawaz; A Baron; R B Jones; E J Shpall; S Nawaz
Journal:  Br J Cancer       Date:  2007-07-03       Impact factor: 7.640

View more
  7 in total

Review 1.  Imaging for Response Assessment in Cancer Clinical Trials.

Authors:  Anna G Sorace; Asser A Elkassem; Samuel J Galgano; Suzanne E Lapi; Benjamin M Larimer; Savannah C Partridge; C Chad Quarles; Kirsten Reeves; Tiara S Napier; Patrick N Song; Thomas E Yankeelov; Stefanie Woodard; Andrew D Smith
Journal:  Semin Nucl Med       Date:  2020-06-10       Impact factor: 4.446

2.  Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Naoko Mori; Hiroyuki Abe; Shunji Mugikura; Minoru Miyashita; Yu Mori; Yo Oguma; Minami Hirasawa; Satoko Sato; Kei Takase
Journal:  Breast Cancer       Date:  2021-04-26       Impact factor: 4.239

3.  Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis.

Authors:  Jennifer Xiao; Habib Rahbar; Daniel S Hippe; Mara H Rendi; Elizabeth U Parker; Neal Shekar; Michael Hirano; Kevin J Cheung; Savannah C Partridge
Journal:  NPJ Breast Cancer       Date:  2021-04-16

4.  Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients.

Authors:  Saki Kamiya; Hiroko Satake; Yoko Hayashi; Satoko Ishigaki; Rintaro Ito; Mariko Kawamura; Toshiaki Taoka; Shingo Iwano; Shinji Naganawa
Journal:  Breast Cancer       Date:  2021-09-16       Impact factor: 4.239

5.  Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement.

Authors:  Soo Yeon Kim; Nariya Cho; Yunhee Choi; Sung Ui Shin; Eun Sil Kim; Su Hyun Lee; Jung Min Chang; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2020-05       Impact factor: 3.500

Review 6.  Ultrafast Dynamic Contrast-enhanced MRI of the Breast: How Is It Used?

Authors:  Masako Kataoka; Maya Honda; Akane Ohashi; Ken Yamaguchi; Naoko Mori; Mariko Goto; Tomoyuki Fujioka; Mio Mori; Yutaka Kato; Hiroko Satake; Mami Iima; Kazunori Kubota
Journal:  Magn Reson Med Sci       Date:  2022-02-25       Impact factor: 2.760

Review 7.  Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction.

Authors:  Meredith A Jones; Warid Islam; Rozwat Faiz; Xuxin Chen; Bin Zheng
Journal:  Front Oncol       Date:  2022-08-31       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.